We see Cardinal Health as a key player in the stock market. The company just shared its Q2 results for calendar year 2025. Revenue hit $60.16 billion, flat from last year and short of the $60.75 billion analysts expected by 1%.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
Pre-market look at EB stock ahead of Q4 2025 earnings on 12 Mar 2026. Forecasts, Meyka grade, and price targets
FLYX-WT stock plunges in pre-market to $-10.24 on AMEX on 15 Jan 2026; heavy volume and anomalous prints require caution
FDVXF stock falls to USD 0.0001 on PNK; top-losers analysis, Meyka grade and model forecasts
CHYL stock drops to $0.001 on 03 Feb 2026; quick CHYL stock analysis, Meyka AI grade and forecast
SLNA stock trades at $0.03 after hours on 08 Jan 2026 with huge volume and mixed fundamentals
Pre-market: EXEEW stock at $0.01 on 06 Feb 2026, down ~99.99%. Read catalysts, Meyka forecast, and analyst grade